Pharma BD Deal Intelligence
Johnson & Johnson / Intra-Cellular Therapies
2025 · Acquisition/Merger · $14.6B · Complete
Announcement Sentiment
100
Strongly positive
Outcome Score
76
Worked — the deal delivered on its rationale.
J&J acquired Intra-Cellular Therapies for $14.6B for neurological drugs.
Key facts
- Announced Jan 13, 2025
- Closed Apr 02, 2025
- Deal value $14.6B
- Deal type Acquisition/Merger
- Therapeutic area Neurology
- Key assets Caplyta
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals